The Chemours Company

The Chemours Company

CC
The Chemours CompanyUS flagNew York Stock Exchange
12.91
USD
+0.06
- -
1.94BMarket Cap
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
37.82
35.46
31.59
29.73
33.45
37.51
33.53
30.17
38.47
45.53
40.82
38.68
38.66
38.45
Basic EPS, GAAP
2.33
2.21
-0.5
0.04
4.04
5.62
-0.32
1.33
3.69
3.85
-1.7
0.46
-2.57
-2.02
Free Cash Flow per Basic Share
1.98
-0.55
-1.86
1.41
1.24
3.63
1.03
3.28
3.26
2.99
1.25
-6.64
0.34
1.45
Dividend per Share
- -
- -
0.58
0.12
0.12
0.84
1
1
0.99
1.03
1
0.99
0.52
0.36
Book Value per Share
17.76
20.27
0.7
0.55
4.7
5.94
4.21
4.93
6.71
7.45
4.96
3.82
1.67
-0.33
Tangible Book Value per Share
16.57
19.12
-0.28
-0.38
3.79
4.88
3.15
3.92
6.04
6.68
4.25
3.49
1.35
-0.64
Basic Weighted Avg Shares
181
181
181
182
185
177
165
165
165
150
149
149
150
151
Sales/Revenue/Turnover
6,859
6,432
5,717
5,400
6,183
6,638
5,526
4,969
6,345
6,831
6,078
5,782
5,808
5,797
Operating Margin (%)
7.76
8.27
3.95
1.41
16.25
18.56
7.46
8.17
10.62
11.51
-2.02
7.28
-0.48
-1.43
Depreciation Expense
261
257
267
284
273
284
311
320
317
291
309
292
340
319
Net Income, GAAP
423
400
-90
7
746
995
-52
219
608
578
-253
69
-386
-304
Effective Tax Rate (%)
26.39
27.09
- -
- -
18.09
13.77
- -
- -
10.06
22
- -
34.91
- -
- -
Profit Margin (%)
6.17
6.22
-1.57
0.13
12.07
14.99
-0.94
4.41
9.58
8.46
-4.16
1.19
-6.65
-5.24
Working Capital
509
543
835
782
1,845
1,584
1,236
1,191
1,487
1,323
1,349
1,197
1,315
1,233
LT Debt
- -
- -
3,915
3,529
4,097
3,959
4,271
4,199
3,903
3,788
4,193
4,257
4,290
4,029
Total Equity
3,217
3,673
130
104
865
1,020
695
815
1,082
1,107
739
572
251
-48
Return on Invested Capital (%)
11.92
11.09
- -
- -
18.76
20.89
- -
- -
11.77
12.08
- -
5.44
- -
- -
Return on Capital (%)
13.09
11.58
- -
- -
21.34
23.32
- -
- -
15.24
14.02
- -
4.82
- -
- -
Return on Common Equity (%)
13.13
11.62
-4.74
6.19
155.42
106.19
-6.11
29.16
64.2
52.83
-27.44
10.55
-94.03
-267.04

Capital Structure

FRC

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
ST Debt
104
99
91
LT Borrowings
4,099
4,100
3,838
LT Finance Leases
191
192
191
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
150
150
150
Market Capitalization
1,767
3,312
3,088

Working Capital

FRC

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
Total Current Assets
3,001
2,928
3,094
Cash, Cash Equivalents & STI
670
563
671
Accounts Receivable, Net
562
645
773
Inventories
1,569
1,536
1,452
Total Current Liabilities
1,686
1,609
1,861
Payables & Accruals
1,389
1,278
1,549
ST Debt
104
99
91
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
63.82%
-15.38%
-56.12%
Free Cash Flow
-67.49%
-162.92%
-105.14%
Net Income, GAAP
909.86%
-151.55%
-659.42%
Sales/Revenue/Turnover
0.94%
3.98%
0.45%
Total Cash Common Dividend
- -
- -
-47.3%

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
1,362
1,554
1,508
1,394
5,782
2025
1,368
1,615
1,495
1,330
5,808
2026
1,381
1,591
- -
- -
- -

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.36
0.4
-0.21
- -
0.46
2025
-0.03
-2.53
0.4
- -
-2.57
2026
-0.19
-1.81
- -
- -
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.25
0.25
0.25
- -
0.99
2025
0.25
0.09
0.09
- -
0.52
2026
0.09
0.09
- -
- -
- -

Company Description

CEO
Denise Dignam
Full Time Employees
5,700
Sector
Basic Materials
Industry
Chemicals - Specialty
Address
1007 Market Street Wilmington DE United States of America 19801
IPO Date
Jun 19, 2015
Business
The Chemours Company (NYSE: CC), founded in 2015 as a spin-off from DuPont's performance chemicals business and headquartered in Wilmington, Delaware, provides performance chemicals essential for industries including automotive, electronics, energy, coatings, and medical applications. The company operates through three core segments: Titanium Technologies, offering Ti-Pure titanium dioxide pigments for coatings, plastics, and paper; Thermal & Specialized Solutions, producing refrigerants such as Opteon and Freon, foam blowing agents, propellants, and industrial fluoropolymers; and Advanced Performance Materials, supplying fluoropolymer resins and derivatives including Teflon, Viton, Nafion, Krytox, and ECCtreme for semiconductors, batteries, and high-performance applications; alongside chemical solutions like sodium cyanide, sulfuric acid, aniline, and mining intermediates. With approximately 6,000 employees and 29 manufacturing facilities across nine countries, Chemours markets its products in 120 countries, generating $5.8 billion in net sales for 2024. Chemours maintains a global presence in North America, Asia-Pacific, Europe, Middle East, Africa, and Latin America, serving roughly 2,900 customers with a focus on high-growth areas such as data center cooling, next-generation refrigerants, electric vehicles, clean energy, and semiconductor fabrication under its Pathway to Thrive strategy. Recent developments include a March 2025 strategic alliance with Energy Fuels Inc. to bolster U.S. domestic supply chains for rare earth elements, titanium, and zirconium minerals, leveraging complementary mining operations in Florida, Georgia, Madagascar, Brazil, and Australia; and August 2025 agreements with SRF Limited in India for manufacturing high-quality fluoroproducts to enhance supply flexibility without capital investment, supporting essential applications by 2026. The company appointed Denise Dignam as President and CEO, alongside leadership additions like Matthew Conti as Chief Human Resources Officer and Nathan Blom as Vice President of Liquid Cooling Growth Portfolio, amid strategic investments in sustainability such as PFAS emission reductions. Chemours reported third-quarter 2025 net sales of $1.495 billion and continues portfolio optimization through prior divestitures including its mining solutions business in 2021 and glycolic acid business in 2023.

Company News

  • CC Shareholder Alert: Investors With Losses May Seek to Lead the Class Action in The Chemours Company Securities Lawsuit - Contact SueWallSt

  • Pomerantz Law Firm Announces the Filing of a Class Action Against The Chemours Company and Certain Officers - CC

  • CC CLASS ACTION NOTICE: Faruqi & Faruqi, LLP Reminds The Chemours Investors of Securities Class Action Lawsuit Deadline on December 7, 2026

  • The Chemours Company (CC) Investors: December 7, 2026, Deadline in Securities Fraud Class Action Lawsuit – Contact Kessler Topaz Meltzer & Check, LLP

  • Portnoy Law Firm Announces Class Action on Behalf of The Chemours Company Investors

  • Bronstein, Gewirtz & Grossman LLC Urges Chemours Company Investors to Act: Class Action Filed Alleging Investor Harm

  • The Chemours Company Securities Fraud Class Action Result of Overstatement of Refrigerant Aftermarket Demand and 18% Stock Decline - Investors may Contact Lewis Kahn, Esq., at Kahn Swick & Foti, LLC

  • CC Shareholder Alert: December 7, 2026 Lead Plaintiff Deadline in The Chemours Company Securities Class Action - Contact Levi & Korsinsky

  • Kaplan Fox Notifies Investors of The Chemours Company (CC) of the Lead Plaintiff Deadline on December 7, 2026

  • CC Shareholder Alert: December 7, 2026 Lead Plaintiff Deadline in The Chemours Company Securities Class Action - Contact Levi & Korsinsky

  • This Chemours Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Wednesday

  • $CC Investors: A Securities Fraud Class Action is Pending on behalf of Chemours Investors that Lost Money after 18% Stock Drop – Contact BFA Law by December 7 Deadline

  • Pomerantz Law Firm Announces the Filing of a Class Action Against The Chemours Company and Certain Officers – CC

  • CC Class Action Notice: Chemours Sued for Securities Fraud After Opteon Demand Issues Lead to 18% Stock Drop – Investors Urged to Contact BFA Law by December 7 Deadline

  • CC INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Reminds The Chemours Investors of Securities Class Action Lawsuit Deadline on December 7, 2026

  • Bronstein, Gewirtz & Grossman LLC Urges Chemours Company Investors to Act: Class Action Filed Alleging Investor Harm

  • CC Stockholder Notice: Shareholder Rights Law Firm Robbins LLP Reminds Investors of the Securities Class Action Lawsuit Against The Chemours Company

  • CC Stockholder Notice: Shareholder Rights Law Firm Robbins LLP Reminds Investors of the Securities Class Action Lawsuit Against The Chemours Company

  • The Chemours Company Securities Fraud Class Action Result of Overstatement of Refrigerant Aftermarket Demand and 18% Stock Decline - Investors may Contact Lewis Kahn, Esq., at Kahn Swick & Foti, LLC

  • The Chemours Company Securities Fraud Class Action Result of Overstatement of Refrigerant Aftermarket Demand and 18% Stock Decline - Investors may Contact Lewis Kahn, Esq., at Kahn Swick & Foti, LLC